Exousia Bio (LMMY) Non-Current Assets (2022 - 2026)

Exousia Bio (LMMY) has 5 years of Non-Current Assets data on file, last reported at $22.1 million in Q1 2026.

• Quarterly Non-Current Assets changed N/A year-over-year to $22.1 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $22.1 million (changed N/A YoY) and the FY2024 annual result came in at $14489.0, down 50.36% from the prior year.
• Non-Current Assets steadied at $22.1 million in Q1 2026 per LMMY's latest filing, from $22.1 million in the prior quarter.
• The five-year high for Non-Current Assets was $22.1 million in Q4 2025, with the low at $7137.0 in Q4 2024.
• Average Non-Current Assets over 5 years is $4.0 million, with a median of $25514.0 recorded in 2023.
• Year-over-year, Non-Current Assets plunged 67.32% in 2024 and surged 308862.73% in 2025.
• Exousia Bio's Non-Current Assets stood at $43889.0 in 2022, then slumped by 50.24% to $21839.0 in 2023, then sank by 67.32% to $7137.0 in 2024, then surged by 308862.73% to $22.1 million in 2025, then changed by 0.0% to $22.1 million in 2026.
• Business Quant data shows LMMY's Non-Current Assets at $22.1 million in Q1 2026, $22.1 million in Q4 2025, and $7137.0 in Q4 2024.